SOLAGRAN LIMITED (SLA)

ASX code: SLA
Listing Date: Thu, 22 Dec 1983
Website: http://www.solagran.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences

Principal Activities:
Research and development of bio-medical products used in the treatment of cirrhosis, chronic hepatitis and other liver conditions.

Address:
492 St Kilda Road, Level 11
MELBOURNE
VIC 3004

Phone: (03) 9820 2699
Fax: (03) 9820 3155

Executives & Directors

Dr Vagif Soultanov, Executive Chairman
Mr Peter Stedwell, Executive Director
Mr Denis Kilroy, Executive Director
Mr Charles Pellegrino, Executive Director

Please contact the ASX to change these details

Company Podcasts

Subscribe to current and future audio events for this company by clicking on the podcast icon:

Company ASX Announcements

Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.

View this company's details on the Australian Securities Exchange website

SOLAGRAN LIMITED (SLA) Events

Company (Stock Code)	Date/Time	Event
SOLAGRAN LIMITED (SLA)	Tue, 15 Jan 2008 11:00AM	SLA - Russian Patent Authority Accepts H.pylori Patent Application - Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Tue, 20 Nov 2007 06:00PM	SLA - Conifer Green Needle Complex - Dr Vladimir Bespalov, Chief of Cancer Chemoprevention, NN Petrov Institute of Oncology, St Petersburg
SOLAGRAN LIMITED (SLA)	Mon, 29 Oct 2007 02:30PM	SLA - Research Report on Solagran - Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Wed, 19 Sep 2007 11:00AM	SLA - EGM Presentation - Mr Denis Kilroy, Executive Director and Mr Peter Stedwell, Executive Director
SOLAGRAN LIMITED (SLA)	Tue, 21 Aug 2007 06:00PM	SLA - Visit by Director of Pasteur Institute and Ropren Update - Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Tue, 7 Aug 2007 11:00AM	SLA - Upcoming General Meeting, Executive Reward Plan - Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Tue, 12 Jun 2007 02:30PM	SLA - Upgrade to Bioeffective® R Manufacturing Capacity - Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Thu, 10 May 2007 02:30PM	SLA - Quarterly Newsletter - Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Mon, 16 Apr 2007 06:00PM	SLA - Agreement with BioProspect - Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Thu, 22 Mar 2007 04:00PM	SLA - Ropren Approval Update - Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Thu, 22 Feb 2007 06:00PM	SLA - Excellent Results from Australian Ropren Trials- Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Wed, 14 Feb 2007 01:00PM	SLA - Activity Update - Mr Denis Kilroy, Executive Director
SOLAGRAN LIMITED (SLA)	Wed, 29 Nov 2006 02:00PM	SLA - 2006 Annual General Meeting, 27/11/06 - Mr Peter Stedwell, Mr Denis Kilroy & Dr Vagif Soultanov
SOLAGRAN LIMITED (SLA)	Wed, 9 Aug 2006 11:00AM	SLA - Investor Update - Mr Denis Kilroy & Mr Peter Stedwell, Executive Directors
SOLAGRAN LIMITED (SLA)	Fri, 29 Aug 2008	Full Year Results
SOLAGRAN LIMITED (SLA)	Fri, 29 Feb 2008	Interim Results
SOLAGRAN LIMITED (SLA)	Fri, 21 Dec 2007 11:00AM	Annual General Meeting Boulevard Room, St Kilda Road Parkview Hotel, 562 St Kilda Road Melbourne Victoria
SOLAGRAN LIMITED (SLA)	Mon, 17 Sep 2007	EGM
SOLAGRAN LIMITED (SLA)	Fri, 31 Aug 2007	Full Year Results
SOLAGRAN LIMITED (SLA)	Wed, 28 Feb 2007	Interim Results
SOLAGRAN LIMITED (SLA)	Mon, 27 Nov 2006 03:00PM	Annual General Meeting St Kilda Road Parkview Hotel, 562 St Kilda Road Melbourne VIC
SOLAGRAN LIMITED (SLA)	Thu, 16 Mar 2006	Interim Results
SOLAGRAN LIMITED (SLA)	Thu, 10 Nov 2005 03:30PM 03:30PM Australia/Victoria	Annual General Meeting
Displaying 1-20 of 23 events		Display

SOLAGRAN LIMITED (SLA)

Click here to view details on the ASX site

Shareholder Information Evening Presentation	Wed, 3 Sep 2008
Appendix 4E	Fri, 29 Aug 2008
Initial Substantial Holder Notice for BPO	Thu, 28 Aug 2008
Approval to Construct New Plant in Tomsk Free Economic Zone	Mon, 25 Aug 2008
BPO: EGUS Screening trial results for Bioeffectives	Fri, 22 Aug 2008
Market Update and Shareholder Briefing	Tue, 19 Aug 2008
Change of Director`s Interest Notice Appendix 3Y	Thu, 14 Aug 2008
Response to an ASX Price Query	Fri, 8 Aug 2008
Completion of Sale of Securities	Thu, 7 Aug 2008
Ceasing to be a substantial holder from ANZ	Thu, 7 Aug 2008

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.